# SEMA3C

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/SEMA3C
> Markdown URL: https://mediated.wiki/source/SEMA3C.md
> Source: https://en.wikipedia.org/wiki/SEMA3C
> Source revision: 1301334875
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

**Semaphorin-3C** is a [protein](/source/Protein) that in humans is encoded by the *SEMA3C* [gene](/source/Gene).[1][2][3]

## References

1. Püschel AW, Adams RH, Betz H (May 1995). "Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension". *Neuron*. **14** (5): 941–8. [doi:10.1016/0896-6273(95)90332-1](https://doi.org/10.1016/0896-6273(95)90332-1). [PMID 7748561](https://pubmed.ncbi.nlm.nih.gov/7748561)

1. Mangasser-Stephan K, Dooley S, Welter C, Mutschler W, Hanselmann RG (May 1997). "Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display". *Biochemical and Biophysical Research Communications*. **234** (1): 153–6. [doi:10.1006/bbrc.1997.6607](https://doi.org/10.1006/bbrc.1997.6607). [PMID 9168980](https://pubmed.ncbi.nlm.nih.gov/9168980)

1. ["Entrez Gene: SEMA3C sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C"](https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=10512)

## Further reading

- Robertson NG, Khetarpal U, Gutiérrez-Espeleta GA, Bieber FR, Morton CC (September 1994). "Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening". *Genomics*. **23** (1): 42–50. [doi:10.1006/geno.1994.1457](https://doi.org/10.1006/geno.1994.1457). [hdl:10669/15162](https://hdl.handle.net/10669/15162). [PMID 7829101](https://pubmed.ncbi.nlm.nih.gov/7829101)
- Bonaldo MF, Lennon G, Soares MB (September 1996). "Normalization and subtraction: two approaches to facilitate gene discovery". *Genome Research*. **6** (9): 791–806. [doi:10.1101/gr.6.9.791](https://doi.org/10.1101/gr.6.9.791). [PMID 8889548](https://pubmed.ncbi.nlm.nih.gov/8889548)
- Chen H, Chédotal A, He Z, Goodman CS, Tessier-Lavigne M (September 1997). "Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III". *Neuron*. **19** (3): 547–59. [doi:10.1016/S0896-6273(00)80371-2](https://doi.org/10.1016/S0896-6273(00)80371-2). [PMID 9331348](https://pubmed.ncbi.nlm.nih.gov/9331348). [S2CID 17985062](https://api.semanticscholar.org/CorpusID:17985062)
- Yamada T, Endo R, Gotoh M, Hirohashi S (December 1997). "Identification of semaphorin E as a non-MDR drug resistance gene of human cancers". *Proceedings of the National Academy of Sciences of the United States of America*. **94** (26): 14713–8. [Bibcode:1997PNAS...9414713Y](https://ui.adsabs.harvard.edu/abs/1997PNAS...9414713Y). [doi:10.1073/pnas.94.26.14713](https://doi.org/10.1073/pnas.94.26.14713). [PMC 25101](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25101). [PMID 9405678](https://pubmed.ncbi.nlm.nih.gov/9405678)
- Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Dionysiou-Asteriou D, Skarlos D, Gonos E (2002). "Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients". *Anticancer Research*. **22** (4): 2275–80. [PMID 12174914](https://pubmed.ncbi.nlm.nih.gov/12174914)
- Rieger J, Wick W, Weller M (June 2003). "Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins". *Glia*. **42** (4): 379–89. [doi:10.1002/glia.10210](https://doi.org/10.1002/glia.10210). [PMID 12730958](https://pubmed.ncbi.nlm.nih.gov/12730958). [S2CID 45643250](https://api.semanticscholar.org/CorpusID:45643250)
- Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Schölmerich J, Straub RH (April 2004). "Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis". *Arthritis and Rheumatism*. **50** (4): 1156–63. [doi:10.1002/art.20110](https://doi.org/10.1002/art.20110). [PMID 15077297](https://pubmed.ncbi.nlm.nih.gov/15077297)
- Beckers J, Herrmann F, Rieger S, Drobyshev AL, Horsch M, Hrabé de Angelis M, Seliger B (April 2005). "Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis". *International Journal of Cancer*. **114** (4): 590–7. [doi:10.1002/ijc.20798](https://doi.org/10.1002/ijc.20798). [PMID 15609325](https://pubmed.ncbi.nlm.nih.gov/15609325). [S2CID 39883399](https://api.semanticscholar.org/CorpusID:39883399)
- Herman JG, Meadows GG (May 2007). "Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells". *International Journal of Oncology*. **30** (5): 1231–8. [doi:10.3892/ijo.30.5.1231](https://doi.org/10.3892/ijo.30.5.1231). [PMID 17390026](https://pubmed.ncbi.nlm.nih.gov/17390026)

---
Adapted from the Wikipedia article [SEMA3C](https://en.wikipedia.org/wiki/SEMA3C) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/SEMA3C?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.